Initiative Increased BRCA Testing in Ovarian Cancer Patients
A multipronged initiative increased germline BRCA mutation testing for patients with ovarian cancer by 31%.
Diagnosis & Disease Information
Women With BRCA1/2 Mutations Have High Risk of Cancer After Age 50
The risk of cancer remains high for women older than 50 years with BRCA1 or BRCA2 mutations, a study suggests.
Genetic Susceptibility to Ovarian Cancer Does Not Modify Protective Effect of Aspirin
Genetic susceptibility to ovarian cancer does not modify the protective effect of frequent aspirin use on ovarian cancer risk, a study suggests.
Cardiovascular Risk Stratification for Older Adults Undergoing Cancer Surgery
Identifying limitations in functional reserves in the older adult leads to improved decision-making related to cardiovascular risk stratification and elective procedures.
Mirvetuximab Soravtansine Could Be New Standard Care for Platinum-Resistant Ovarian Cancer
Mirvetuximab soravtansine has shown activity in a phase 2 trial of biomarker-selected patients with platinum-resistant ovarian cancer.
Ultra-Processed Food Linked to Increased Risk of Cancer and Death
The consumption of ultra-processed foods is associated with an increased risk of developing cancer and dying from it, a large study suggests.
Experts Say Even Low-Risk Patients Should Remove Fallopian Tubes to Avoid Cancer
More patients should consider having their fallopian tubes removed to prevent ovarian cancer, according to the Ovarian Cancer Research Alliance.
Purchasing Data Could Be Used to Predict Ovarian Cancer, Researchers Say
Purchases of over-the-counter pain and indigestion medications could be used to predict ovarian cancer months before diagnosis, a study suggests.
Risk of Sexual Dysfunction Higher for Survivors of Gynecologic Cancers
Compared with the general population, survivors of gynecologic cancers have a higher risk of sexual dysfunction 1 to 5 years after cancer diagnosis.
Barriers to Access Do Not Fully Explain Disparities in Ovarian Cancer Treatment
Non-Hispanic Black patients are less likely than Hispanic or non-Hispanic White patients to receive guideline-recommended treatment for ovarian cancer.
- Loading...
Loading...
Next post in Gynecologic Cancer
Loading... 
Loading...